Why it matters
The immediate effect is in the UK, where people will no longer be able to get this vaccine. The article identifies no direct effect on the United States.
DRUGS, DEVICES & RECALLS • UNITED KINGDOM
UK withdraws chikungunya vaccine after safety review
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
The UK has withdrawn access to the IXCHIQ chikungunya vaccine after a review of serious adverse reactions reported since its approval. Reports included symptoms resembling chikungunya and rare neurological events; the article does not provide a rate or establish how often these events occur.
HOW THIS BRIEF WAS MADE 1 outlet: 1 specialist. Automated sourcing and summaries by the BLUF engine. Corrections